Susquehanna International Group, LLP Ocugen, Inc. Put Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$0.98 - $1.95 $250,096 - $497,640	255,200 Added 303.45%	339,300 $335,000
Q2 2024 Aug 15, 2024	BUY	$1.18 - $1.98 $59,590 - $99,990	50,500 Added 150.3%	84,100 $130,000
Q1 2024 May 07, 2024	SELL	$0.5 - $1.83 $18,650 - $68,259	-37,300 Reduced 52.61%	33,600 $55,000
Q4 2023 Feb 14, 2024	SELL	$0.36 - $0.57 $4,752 - $7,523	-13,200 Reduced 15.7%	70,900 $40,000
Q3 2023 Nov 14, 2023	SELL	$0.4 - $0.62 $19,440 - $30,132	-48,600 Reduced 36.62%	84,100 $33,000
Q2 2023 Aug 11, 2023	BUY	$0.45 - $0.88 $3,015 - $5,896	6,700 Added 5.32%	132,700 $71,000
Q1 2023 May 16, 2023	SELL	$0.82 - $1.33 $2,624 - $4,256	-3,200 Reduced 2.48%	126,000 $107,000
Q4 2022 Feb 14, 2023	SELL	$1.11 - $1.87 $309,690 - $521,730	-279,000 Reduced 68.35%	129,200 $167,000
Q3 2022 Nov 14, 2022	SELL	$1.75 - $3.1 $232,750 - $412,300	-133,000 Reduced 24.58%	408,200 $727,000

125

78.3M

535K

523K

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $204M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.